CSL shareholders revolt against executive pay packages
Australian biotech giant CSL faces investor fury as shareholders overwhelmingly vote against executive pay, though board members narrowly survive removal votes amid share price concerns.
Australian biotech giant CSL faces investor fury as shareholders overwhelmingly vote against executive pay, though board members narrowly survive removal votes amid share price concerns.
The House of Commons' top official enjoys a staggering £750,000 annual remuneration, with an additional £900,000 added to their pension pot over two years, sparking outrage amid economic struggles.
The CEO of Nationwide Building Society sees a significant rise in remuneration as the mutual reports strong financial performance.